These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1510705)

  • 1. Primaquine metabolism by human liver microsomes: effect of other antimalarial drugs.
    Bangchang KN; Karbwang J; Back DJ
    Biochem Pharmacol; 1992 Aug; 44(3):587-90. PubMed ID: 1510705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mefloquine metabolism by human liver microsomes. Effect of other antimalarial drugs.
    Bangchang KN; Karbwang J; Back DJ
    Biochem Pharmacol; 1992 May; 43(9):1957-61. PubMed ID: 1596283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes.
    Baune B; Furlan V; Taburet AM; Farinotti R
    Drug Metab Dispos; 1999 May; 27(5):565-8. PubMed ID: 10220483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes.
    Zhao XJ; Ishizaki T
    Br J Clin Pharmacol; 1997 Nov; 44(5):505-11. PubMed ID: 9384469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine.
    Constantino L; Paixão P; Moreira R; Portela MJ; Do Rosario VE; Iley J
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):299-303. PubMed ID: 10445386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.
    Ganesan S; Tekwani BL; Sahu R; Tripathi LM; Walker LA
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):14-22. PubMed ID: 19616568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems.
    Halliday RC; Jones BC; Smith DA; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1995 Oct; 40(4):369-78. PubMed ID: 8554939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
    Walker DK; Alabaster CT; Congrave GS; Hargreaves MB; Hyland R; Jones BC; Reed LJ; Smith DA
    Drug Metab Dispos; 1996 Apr; 24(4):447-55. PubMed ID: 8801060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.
    Portela MJ; Moreira R; Valente E; Constantino L; Iley J; Pinto J; Rosa R; Cravo P; do Rosário VE
    Pharm Res; 1999 Jun; 16(6):949-55. PubMed ID: 10397619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine.
    Fasinu PS; Tekwani BL; Avula B; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan IA; Walker LA
    Malar J; 2016 Sep; 15(1):466. PubMed ID: 27618912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine.
    Zhang H; Coville PF; Walker RJ; Miners JO; Birkett DJ; Wanwimolruk S
    Br J Clin Pharmacol; 1997 Mar; 43(3):245-52. PubMed ID: 9088578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver microsomes.
    Lee SH; Slattery JT
    Drug Metab Dispos; 1997 Dec; 25(12):1354-8. PubMed ID: 9394024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aliphatic side-chain substituents on the antimalarial activity and on the metabolism of primaquine studied using mitochondria and microsome preparations.
    Baker JK; Yarber RH; Nanayakkara NP; McChesney JD; Homo F; Landau I
    Pharm Res; 1990 Jan; 7(1):91-5. PubMed ID: 2300544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
    Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mefloquine on hepatic drug metabolism in the rat: comparative study with primaquine.
    Riviere JH; Back DJ
    Biochem Pharmacol; 1985 Feb; 34(4):567-71. PubMed ID: 3871613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of rat hepatic mixed function oxidases by antimalarial drugs: selectivity for cytochromes P-450 and P-448.
    Thabrew MI; Ioannides C
    Chem Biol Interact; 1984 Oct; 51(3):285-94. PubMed ID: 6488390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.
    Brandes LJ; Queen GM; LaBella FS
    Cancer Chemother Pharmacol; 2000; 45(4):298-304. PubMed ID: 10755318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences.
    Jamis-Dow CA; Klecker RW; Katki AG; Collins JM
    Cancer Chemother Pharmacol; 1995; 36(2):107-14. PubMed ID: 7767945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes.
    Haaz MC; Riché C; Rivory LP; Robert J
    Drug Metab Dispos; 1998 Aug; 26(8):769-74. PubMed ID: 9698291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of 4'-(p-toluenesulfonylamide)-4-hydroxychalcone using human liver microsomes and recombinant cytochrome P450s.
    Lee B; Wu Z; Lee T; Tan XF; Park KH; Liu KH
    Xenobiotica; 2016; 46(4):350-6. PubMed ID: 26330107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.